For complete details about these proceedings, click here.
PMNOC Actions
glatiramer acetate 20 mg/mL and 40 mg/mL prefilled syringes (COPAXONE): Teva v Pharmascience
glatiramer acetate 40 mg/mL prefilled syringes (COPAXONE): Teva v Pharmascience
liraglutide 6 mg/mL prefilled pens (VICTOZA): Novo Nordisk v Teva
abiraterone acetate (ZYTIGA): Janssen and BTG v Apotex
apixaban (ELIQUIS): Bristol-Myers Squibb v Pharmascience
apixaban (ELIQUIS): Bristol-Myers Squibb and Pfizer v Pharmascience
apixaban (ELIQUIS): Bristol-Myers Squibb and Pfizer v Natco Pharma
The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.
